Literature DB >> 10770257

Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.

T Kubo1, H Yamaguchi, M Tsujimura, Y Hagiwara, R Fukumori.   

Abstract

It has been established that deoxycorticosterone acetate (DOCA)-salt hypertensive rats have an overactive brain angiotensin-system. The purpose of the present study was to identify the brain sites showing enhanced angiotensin-system activity responsible for the pathogenesis of hypertension in DOCA-salt hypertensive rats. The angiotensin receptor antagonist, losartan, was injected into brain ventricles or into tissues around the rostral parts of the third ventricle in conscious DOCA-salt hypertensive rats. Losartan (1 microg) injection into the lateral ventricle or into the rostral parts of the third ventricle produced a depressor response, whereas the agent did not affect blood pressure when injected into the caudal parts of the third ventricle or into the fourth ventricle. Losartan (0.1 microg) injection into the anterior hypothalamic preoptic area, anterior (AHA) produced a depressor response. Angiotensin II (0.1-1 ng) injection into the AHA produced a pressor response in sham-operated and DOCA-salt hypertensive rats, and the pressor response to angiotensin II (1 ng) was greater in DOCA-salt hypertensive rats than that in sham-operated rats. Release of angiotensin peptides in the AHA was greater in DOCA-salt hypertensive rats than that in sham-operated rats. These findings suggest that the angiotensin-system in the AHA is enhanced, and that this enhancement is involved in the maintenance of hypertension in DOCA-salt hypertensive rats. Both increased pressor reactivity to angiotensin II and increased release of angiotensin peptides in the AHA appear to be related to this enhancement of the angiotensin-system in DOCA-salt hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770257     DOI: 10.1291/hypres.23.109

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  21 in total

1.  Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism.

Authors:  Kristin E Claflin; Jeremy A Sandgren; Allyn M Lambertz; Benjamin J Weidemann; Nicole K Littlejohn; Colin M L Burnett; Nicole A Pearson; Donald A Morgan; Katherine N Gibson-Corley; Kamal Rahmouni; Justin L Grobe
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

Review 2.  Control of energy balance by the brain renin-angiotensin system.

Authors:  Kristin E Claflin; Justin L Grobe
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

3.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

4.  Brain endoplasmic reticulum stress mechanistically distinguishes the saline-intake and hypertensive response to deoxycorticosterone acetate-salt.

Authors:  Fusakazu Jo; Hiromi Jo; Aline M Hilzendeger; Anthony P Thompson; Martin D Cassell; D Thomas Rutkowski; Robin L Davisson; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

5.  Selective Deletion of Renin-b in the Brain Alters Drinking and Metabolism.

Authors:  Keisuke Shinohara; Pablo Nakagawa; Javier Gomez; Donald A Morgan; Nicole K Littlejohn; Matthew D Folchert; Benjamin J Weidemann; Xuebo Liu; Susan A Walsh; Laura L Ponto; Kamal Rahmouni; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

6.  Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice.

Authors:  Justin L Grobe; Beth A Buehrer; Aline M Hilzendeger; Xuebo Liu; Deborah R Davis; Di Xu; Curt D Sigmund
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

7.  Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.

Authors:  Baojian Xue; Terry G Beltz; Yang Yu; Fang Guo; Celso E Gomez-Sanchez; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-26       Impact factor: 4.733

8.  Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.

Authors:  Wencheng Li; Michelle N Sullivan; Sheng Zhang; Caleb J Worker; Zhenggang Xiong; Robert C Speth; Yumei Feng
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

9.  Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.

Authors:  Nicole K Littlejohn; Rick B Siel; Pimonrat Ketsawatsomkron; Christopher J Pelham; Nicole A Pearson; Aline M Hilzendeger; Beth A Buehrer; Benjamin J Weidemann; Huiping Li; Deborah R Davis; Anthony P Thompson; Xuebo Liu; Martin D Cassell; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

10.  Exploration of cardiometabolic and developmental significance of angiotensinogen expression by cells expressing the leptin receptor or agouti-related peptide.

Authors:  Sarah A Sapouckey; Lisa L Morselli; Guorui Deng; Chetan N Patil; Kirthikaa Balapattabi; Vanessa Oliveira; Kristin E Claflin; Javier Gomez; Nicole A Pearson; Matthew J Potthoff; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-03-18       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.